Our combined treatment exploits the immunostimulatory properties of both IFNα and TLR7/8 signaling and is effective in the treatment of primary tumors, while protecting form metastasis and tumor relapse by inducing immunological memory (Fig. 8h). Here, IFNA2 is linked to neoplasm.